Pharmaceutical composition and process

Pharmaceutical composition and process

  • CN 1,105,271 A
  • Filed: 08/02/1994
  • Published: 07/19/1995
  • Est. Priority Date: 08/02/1993
  • Status: Abandoned Application
First Claim
Patent Images

1. , be used for substituting form by the pathology reason or the people be the damaged conjugate of skeleton that causes, this conjugate contains the porous hydroxyapatite of 0-99.9% (weight ratio) and/or the 7-isopropoxy isoflavone of tricalcium phosphate and 0.001-100% (weight ratio), the discrete particles form of optional active ingredient.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×